Merit’s Flexi Pod to fast-track pharma plant

Piramal’s planned manufacturing facility in Grangemouth

Piramal Pharma Solutions’s new antibody drug conjugate (ADC) manufacturing facility in Grangemouth will be erected by Merit Health using its proprietary Flexi Pod modular system.

With demand growing for ADCs – they are used in targeted cancer treatment but have a wider potential for further applications – Piramal wanted a fast-track solution to increase manufacturing capacity.

Merit Health launched Flexi Pod in 2020 in response to client requests for fast-track solutions for technically complex building. It is a hybrid of traditional shell and core with offsite manufactured fit-out, which is suited to larger technical buildings such as biopharma facilities and hospitals. With a 75-80% offsite manufactured value, Flexi Pod also provides benefits in terms of plant space reduction and services distribution, while delivering enhanced technical performance and energy performance, Merit says.

Merit Health chief executive Tony Wells said: “We are delighted to be working on another important manufacturing facility expansion project, showing that the UK life sciences sector is on a significant and rapid growth trajectory. We understand that speed and cost-efficiency combined with minimised risk and successful ‘right first time’ validation are crucial for the timely development of such treatments. Our offsite offering was developed to support these imperatives meaning that critical therapies and products are in production and manufacturing significantly quicker than traditional methods of construction can offer.”

Got a story? Email

Source link